IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CVKD

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Cash & Equivalents2.392.314.013.865.007.3410.004.365.046.578.409.113.234.030.03
Total Current Assets5.582.864.324.085.977.9410.114.675.447.038.499.283.524.440.73
Property, Plant & Equipment0.000.000.010.010.000.000.010.000.000.000.000.000.000.000.00
Total Non-current Assets*0.000.010.010.010.010.010.010.010.010.020.030.030.040.040.05
Total Assets5.592.864.334.095.987.9510.124.685.467.058.529.313.564.480.78
Accounts Payable0.870.820.650.610.901.281.500.500.760.400.170.140.080.120.40
Short-term Debt--------------------------0.830.60
Total Current Liabilities1.501.061.591.351.681.842.681.271.460.860.830.560.370.401.33
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.010.024.99
Total Liabilities1.501.061.591.351.681.842.681.271.460.860.830.570.380.426.33
Retained Earnings(44.78)(41.46)(38.96)(35.92)(33.24)(29.57)(25.72)(21.54)(19.13)(16.73)(15.07)(13.93)(12.89)(11.89)(6.71)
Total Stockholder Equity4.091.802.742.734.306.117.443.413.996.197.698.753.184.07(5.55)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Cost of Revenue----------------------0.000.22--
Research & Development0.710.770.670.691.081.671.540.781.250.633.650.240.090.09
Selling, General & Admin2.631.742.402.042.662.252.741.671.211.130.900.900.780.96
Total Operating Expenses3.342.513.072.733.733.934.282.462.471.761.261.141.034.20
Operating Income(3.34)(2.51)(3.07)(2.73)(3.73)(3.93)(4.28)(2.46)(2.47)(1.76)(1.26)(1.14)(1.03)(4.20)
Interest Expense----------------------0.010.010.00
Net Income(3.32)(2.50)(3.04)(2.69)(3.67)(3.85)(4.19)(2.41)(2.39)(1.66)(1.14)(1.04)(1.00)(5.17)
Basic EPS(1.14)(1.04)(1.37)(1.31)(1.87)(2.09)(6.30)(2.18)(0.15)(0.10)0.02(0.07)(0.09)(0.48)
Diluted EPS(1.14)(1.04)(1.37)(1.31)(1.87)(2.09)(6.30)(2.18)(0.15)(0.10)0.02(0.07)(0.09)(0.48)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Operating Cash Flow(2.23)(3.00)(2.57)(2.36)(3.03)(4.65)(1.79)(2.20)(1.53)(1.84)(0.69)(0.63)(0.80)(1.41)
Capital Expenditures----0.000.000.000.00--------0.000.000.00--
Free Cash Flow*----(2.57)(2.36)(3.03)(4.65)--------(0.69)(0.63)(0.80)--
Investing Cash Flow0.00--0.00-0.000.00-0.00--------0.00-0.00-0.00--
Financing Cash Flow2.311.302.720.651.261.977.451.530.000.00(0.01)6.510.005.41
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ4 2025Q3 2025Q2 2025Q1 2025
Dividends Per Share0.000.000.0016.50
← Scroll for more columns →